In patients with diabetic wounds, copper oxide impregnated dressings were noninferior to standard negative pressure wound therapy.

Dr Joshua D Safer and Dr C Streed Jr discuss the importance of cardiovascular care among transgender and gender-diverse patients.

GLP-1RAs were associated with improved quality of life and emotional eating behaviors among individuals with overweight and obesity.

Patients with AAV who received avacopan vs standard glucocorticoid-based regimens had lower exposure-adjusted rates of AEs, infections, and neutropenia/lymphopenia.

For patients with advanced or recurrent endometrial cancer, dostarlimab plus carboplatin-paclitaxel treatment is associated with improved survival and maintenance of quality of life.

Compared to their cisgender peers, transgender and gender-questioning adolescents were exposed to more adverse childhood experiences.

In Texas, frequent mental distress among women and the implementation of an abortion ban were significantly associated.

Stressor-evoked brain activity in midlife adults is linked to preclinical atherosclerosis via stress-related blood pressure.

For patients with CKD and T2D, combination finerenone plus empagliflozin leads to a greater reduction in the urinary albumin-to-creatinine ratio than either agent alone.

When discussing fertility preservation options among transgender patients, it is critical to keep barriers to access in mind.

Both CPAP and tirzepatide are acceptable treatments for comorbid obesity and OSA, with providers favoring CPAP and patients preferring tirzepatide.

The FDA has granted de novo authorization to CLAIRITY BREAST, a first-in-class, image-based platform that can help predict a woman's risk for breast cancer.